Should I buy Alignment Healthcare, Inc. (ALHC) stock or is it too late?

Alignment Healthcare, Inc. · Health Care · price $8

See the full Alignment Healthcare, Inc. (ALHC) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 59% of its targets hit on this sector (76 calls tested). It aims for $9 (+8.4 %), call made on October 13, 2026, maturing on October 13, 2027 (1 d ago).

The 1 reliable analyst $9+8.4 %

The 5 other firms $12+45 %

How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $9 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Alignment Healthcare, Inc.

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Stifel	100 %	+81.1 %	6	$23 +177%
Piper Sandler	57 %	+9.4 %	7	$30 +261%
Raymond James	38 %	-14.3 %	8	$19 +129%
Goldman Sachs	0 %	-23.9 %	6	$21 +153%
Barclays	0 %	-57.0 %	7	$10 +20%
Morgan Stanley	25 %	-15.3 %	8	—

In short — Should you invest in Alignment Healthcare, Inc.? Is it too late, still worth it? Analysts are fairly positive (57% buy, median target $11, i.e. +33%), and the most reliable on ALHC targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $11, i.e. +33% from the current price ($8).
The most reliable firm on ALHC, TD Cowen (67% hit rate, 3 scored calls), targets $12 (call made on October 12, 2026, maturing on October 12, 2027) (+45%) in its most recent call, and $25 (call made on January 16, 2026, maturing on January 16, 2027) (+201%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 7 ratings, 3 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on ALHC

Median target $11 (+33%) · 7 ratings · Buy consensus

Strong Buy00%

Buy457%

Hold343%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Alignment Healthcare, Inc. now?

We won't decide for you. The facts: 57% of analysts rate it a buy, median target $11 (+33%), and TD Cowen (most reliable on ALHC, 67%) targets $12. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Alignment Healthcare, Inc.?

Not according to analysts: the median target ($11) is still +33% above the current price ($8) (most reliable on ALHC: TD Cowen, 67%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Alignment Healthcare, Inc. still worth investing in?

It depends on the gap between the price ($8) and its estimated value: analysts target $11 on median (+33%), with 57% buys (most reliable on ALHC: TD Cowen, 67%). Cross-check with their real reliability on ALHC and the cautions above. Information, not advice.

What's the main risk in buying ALHC?

The consensus is not unanimous: of 7 ratings, 3 are neutral.

→ Go deeper: the full Alignment Healthcare, Inc. profile (consensus, analyst reliability, price target, performance).